| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/07/2007 | CN1908009A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1908008A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1298862C Glycoprotein and process for producing same |
| 02/07/2007 | CN1298847C Process for electric field enhanced solid fermentation preparation of cellulase |
| 02/07/2007 | CN1298742C A fusion protein suitable to highly effective expression and production method thereof |
| 02/06/2007 | US7173121 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/06/2007 | US7173119 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173112 Antibody to GALP and uses thereof |
| 02/06/2007 | US7173111 Detecting human infant kidney tumor; genetic engineered polypeptide |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172890 Glucose dehydrogenase varient having less residual enzymatic activity relative to wild type; retains coenzyme binding; amino acid sequence with substitution mutation with fused segment capable of forming metal chelate; DNA sequences encoding oxidoreductase apoenzyme; gene expression and engineering |
| 02/06/2007 | US7172885 Thermostable omega-transaminases |
| 02/06/2007 | US7172880 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 02/06/2007 | US7172873 Methods of detecting early renal disease in animals |
| 02/06/2007 | US7172872 Assays for mastitis detecting haptoglobin in milk |
| 02/06/2007 | US7172862 FBL2-specific agents as modulators of Flaviviridae RNA replication |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172758 Reducing occurrence of occlusions following treatment for arterial atherosclerotic disease; injecting into the blood-stream , prior to performing the angioplasty, a quantity of a bispecific antibody with two antigen binding sites |
| 02/06/2007 | CA2389742C Plant photoperiod sensitivity gene and use of the same |
| 02/06/2007 | CA2241367C Vector for expression of n-terminally extended proteins in yeast cell |
| 02/06/2007 | CA2236113C Negative strand rna viral vector having autonomous replication capability |
| 02/06/2007 | CA2171557C A secretion sequence for the production of a heterologous protein in yeast |
| 02/06/2007 | CA2166479C Density enhanced protein tyrosine phosphatases |
| 02/01/2007 | WO2007014258A2 Growth hormone secretagogues |
| 02/01/2007 | WO2007014197A2 Yeast expression vectors for production of itf |
| 02/01/2007 | WO2007014179A2 Method for controlling immunodominance |
| 02/01/2007 | WO2007014162A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 02/01/2007 | WO2007013603A1 Lymphangiogenesis promoter |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013426A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | WO2007013391A1 Interferon-inducible molecule ips-1 |
| 02/01/2007 | WO2006131643A3 Method for enriching lignocellulose residues with yeast protein |
| 02/01/2007 | WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/01/2007 | WO2006118550A3 Highly productive recombinant yeast strains with modified galactose-regulated transcription |
| 02/01/2007 | WO2006116260A3 Modulation of antibody effector function by hinge domain engineering |
| 02/01/2007 | WO2006089023A3 Pharmaceutical compositions for treating or preventing bone conditions |
| 02/01/2007 | WO2006066229A3 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 02/01/2007 | WO2006049983A3 Peptide yy modified transferrin fusion proteins |
| 02/01/2007 | WO2006017206A3 Flavivirus vaccine |
| 02/01/2007 | WO2006007411A3 Methods and compositions for modulating bax-mediated apoptosis |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2004067709A3 Identification of essential genes of aspergillus fumigatus and methods of use |
| 02/01/2007 | US20070028329 Diacylglycerol acyltransferase genes, proteins, and uses thereof |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027308 Expressed sequence tags and encoded human proteins |
| 02/01/2007 | US20070027306 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin; hypoglycemic agents, analgesics; retinopathy, cardiovascular disease, obesity, renal disease, neuropathy |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027291 Structure and method for producing structure, toner containing structure, image forming method and device using toner |
| 02/01/2007 | US20070027095 Using nicotinamide riboside-related prodrug for treatment and prevention of cell proliferative disorders |
| 02/01/2007 | US20070027084 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070026501 Immunogen, composition for immulogical use and process for producing antibody using the same |
| 02/01/2007 | US20070026500 Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof |
| 02/01/2007 | US20070026499 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field |
| 02/01/2007 | US20070026498 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/01/2007 | US20070026497 Method for controlling metallophosphate precipitation in high cell density fermentations |
| 02/01/2007 | US20070026496 Process for Producing Polypeptides |
| 02/01/2007 | US20070026495 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026493 System and method for optimizing animal production using genotype information |
| 02/01/2007 | US20070026492 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 02/01/2007 | US20070026491 Nucleotide sequences coding cytosine deaminase with enhanced ability to convert 5-fluorocytosine to its toxic form for use in treatment of cancer; antitumor agents |
| 02/01/2007 | US20070026489 Vegetarian protein a preparation and methods thereof |
| 02/01/2007 | US20070026488 Biosynthesis of bryostatins by polyketide synthases (PKS) |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026486 chimera; nuclear factor kappa beta; vectors, host cell; gene therapy; pharmacokinetics |
| 02/01/2007 | US20070026485 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/01/2007 | US20070026484 Method to increase hydrophobic compound titer in a recombinant microorganism |
| 02/01/2007 | US20070026474 provides highly purified polypeptides and antibodies for use in accurate assays |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026463 Compositions and methods of mutant Nogo-66 domain proteins |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026455 Method of producing hybridoma and utilization thereof |
| 02/01/2007 | US20070026452 Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026448 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 02/01/2007 | US20070026437 Novel BMP products |
| 02/01/2007 | US20070026431 Modulation of MAPK-mediated phosphorylation and/or FBXW8-mediated ubiquitinylation of cyclin D1 in modulation of cellular proliferation |
| 02/01/2007 | US20070026428 Combinatorial expression of split caspase molecules |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026420 Novel EGIII-like enzymes, DNA encoding such enzymes and methods for producing such enzymes |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026104 Alcohol dehydrogenase gene of acetic acid bacterium |
| 02/01/2007 | US20070026010 Purification process for bacterial cytolysin |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025992 Monoclonal antibody against platelet membrane glycoprotein VI |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025974 Amylases producing an altered immunogenic response and methods of making and using the same |
| 02/01/2007 | US20070025971 Substances causing differentiation |